Milestone Pharmaceuticals (MIST) Interest & Investment Income (2018 - 2021)
Milestone Pharmaceuticals (MIST) posted Interest & Investment Income of $34000.0 for Q4 2021, down 29.17% on a QoQ basis from $48000.0 in Q3 2021, and down 64.58% year-over-year from $96000.0 in Q4 2020.
Milestone Pharmaceuticals (MIST) Interest & Investment Income (2018 - 2021) Analysis & Trends
Milestone Pharmaceuticals' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $34000.0 for Q4 2021.
- Quarterly Interest & Investment Income fell 64.58% year-over-year to $34000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $220000.0 (down 69.7% YoY) and the FY2021 annual result came in at $220000.0, down 69.7% from the prior year.
- Interest & Investment Income was $34000.0 for Q4 2021 at Milestone Pharmaceuticals, down from $48000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $821000.0 in Q3 2019 and bottomed at $34000.0 in Q4 2021.
- A 4-year average of $265750.0 and a median of $93000.0 in 2018 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2019 — Interest & Investment Income surged 865.88% — and 2020, when it sank 89.16%.
- Milestone Pharmaceuticals' Interest & Investment Income stood at $446000.0 in 2018, then surged by 35.2% to $603000.0 in 2019, then slumped by 84.08% to $96000.0 in 2020, then sank by 64.58% to $34000.0 in 2021.
- Business Quant data shows MIST's Interest & Investment Income at $34000.0 in Q4 2021, $48000.0 in Q3 2021, and $58000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Milestone Pharmaceuticals | 148.53 Mn | -35.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 58,000.00 |
| Mar 31, 2021 | 80,000.00 |
| Dec 31, 2020 | 96,000.00 |
| Sep 30, 2020 | 89,000.00 |
| Jun 30, 2020 | 126,000.00 |
| Mar 31, 2020 | 415,000.00 |
| Dec 31, 2019 | 603,000.00 |
| Sep 30, 2019 | 821,000.00 |
| Jun 30, 2019 | 672,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 446,000.00 |
| Sep 30, 2018 | 85,000.00 |
| Jun 30, 2018 | 89,000.00 |
| Mar 31, 2018 | 90,000.00 |